[{"address1": "4040 Campbell Avenue", "address2": "Suite 100", "city": "Menlo Park", "state": "CA", "zip": "94025", "country": "United States", "phone": "877 266 1144", "fax": "650 352 4401", "website": "https://www.sightsciences.com", "industry": "Medical Devices", "sector": "Healthcare", "longBusinessSummary": "Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. It operates through two segments, Surgical Glaucoma and Dry Eye. The company's products include OMNI Surgical System, an implant-free glaucoma surgery technology indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma; and SION Surgical Instrument, a manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. It also offers TearCare System, a wearable eyelid technology for adult patients with evaporative dry eye disease due to meibomian gland dysfunction, as well as related components. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. Sight Sciences, Inc. was incorporated in 2010 and is headquartered in Menlo Park, California.", "fullTimeEmployees": 214, "companyOfficers": [{"maxAge": 1, "name": "Mr. Paul  Badawi", "age": 48, "title": "Co-Founder, President, CEO & Director", "yearBorn": 1975, "fiscalYear": 2023, "totalPay": 871592, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David  Badawi M.D.", "age": 53, "title": "Founder, CTO & Director", "yearBorn": 1970, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Alison Perry Bauerlein", "age": 42, "title": "CFO & Treasurer", "yearBorn": 1981, "fiscalYear": 2023, "totalPay": 378598, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Matthew W. Link", "age": 48, "title": "Chief Commercial Officer", "yearBorn": 1975, "fiscalYear": 2023, "totalPay": 157614, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Sam Boong Park", "age": 62, "title": "Chief Operating Officer", "yearBorn": 1961, "fiscalYear": 2023, "totalPay": 531785, "exercisedValue": 0, "unexercisedValue": 244603}, {"maxAge": 1, "name": "Mr. Jeremy B. Hayden", "age": 53, "title": "Chief Legal Officer", "yearBorn": 1970, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Steve R. Tamayo Jr.", "title": "VP and Chief Ethics & Compliance Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Reay H. Brown M.D.", "title": "Chief Medical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Stephen B. Thau J.D.", "title": "Secretary", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jim  Rodberg", "title": "VP of Finance & Corporate Controller", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 3, "boardRisk": 3, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1730419200, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 5.0, "open": 5.01, "dayLow": 5.01, "dayHigh": 5.327, "regularMarketPreviousClose": 5.0, "regularMarketOpen": 5.01, "regularMarketDayLow": 5.01, "regularMarketDayHigh": 5.327, "beta": 2.704, "forwardPE": -6.766234, "volume": 148630, "regularMarketVolume": 148630, "averageVolume": 165071, "averageVolume10days": 168600, "averageDailyVolume10Day": 168600, "bid": 5.19, "ask": 5.23, "bidSize": 400, "askSize": 400, "marketCap": 262101040, "fiftyTwoWeekLow": 1.575, "fiftyTwoWeekHigh": 8.45, "priceToSalesTrailing12Months": 3.3012285, "fiftyDayAverage": 6.147, "twoHundredDayAverage": 5.8155, "currency": "USD", "enterpriseValue": 178949024, "profitMargins": -0.65900004, "floatShares": 30631108, "sharesOutstanding": 50307300, "sharesShort": 1115220, "sharesShortPriorMonth": 1044378, "sharesShortPreviousMonthDate": 1726185600, "dateShortInterest": 1728950400, "sharesPercentSharesOut": 0.0222, "heldPercentInsiders": 0.20076999, "heldPercentInstitutions": 0.50958997, "shortRatio": 7.77, "shortPercentOfFloat": 0.030299999, "bookValue": 2.027, "priceToBook": 2.570301, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -52321000, "trailingEps": -1.06, "forwardEps": -0.77, "enterpriseToRevenue": 2.254, "enterpriseToEbitda": -3.495, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "SGHT", "underlyingSymbol": "SGHT", "shortName": "Sight Sciences, Inc.", "longName": "Sight Sciences, Inc.", "firstTradeDateEpochUtc": 1626355800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "d238e934-845b-319d-8b53-34e9246cc0af", "gmtOffSetMilliseconds": -18000000, "currentPrice": 5.21, "targetHighPrice": 10.0, "targetLowPrice": 6.0, "targetMeanPrice": 7.38, "targetMedianPrice": 7.0, "recommendationMean": 2.6, "recommendationKey": "hold", "numberOfAnalystOpinions": 5, "totalCash": 118177000, "totalCashPerShare": 2.349, "ebitda": -51198000, "totalDebt": 35025000, "quickRatio": 10.393, "currentRatio": 11.012, "totalRevenue": 79395000, "debtToEquity": 34.461, "revenuePerShare": 1.612, "returnOnAssets": -0.19364001, "returnOnEquity": -0.44009998, "freeCashflow": -19907000, "operatingCashflow": -35566000, "revenueGrowth": -0.09, "grossMargins": 0.85804003, "ebitdaMargins": -0.64485, "operatingMargins": -0.592, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-11-04"}]